Fellowship Program Director: Peter A. Pinto, M.D.
This fellowship, accredited by the Society of Urologic Oncology, is a two- to three-year program in clinical service and laboratory training for urologic surgeons at the National Cancer Institute, National Institutes of Health, Bethesda MD.
Clinical training during first year includes rotation to urological surgery service; provides consult service to patients, care for inpatients/outpatients on clinical protocols, and performs surgery. From 12-24 months, time is devoted to basic or clinical science research in laboratories/clinical programs, and one can choose to concentrate in either field. Fellows have their own patients which they follow to develop an understanding of care continuity and multidisciplinary management of patients with urologic cancers. Core curriculum covers prostate, bladder, kidney, testis and penile cancer plus experience with advanced minimally invasive surgical techniques and management of patients with locally advanced and advanced genitourinary malignancies and systemic therapy. The “bench-to-bedside” proximity in the new Mark O. Hatfield Clinical Research Center provides a crucial link in rapidly moving biomedical findings in the laboratory into the mainstream of clinical practice. The Clinical Center combines research laboratories with a 250 bed hospital. There are currently over 1,500 active clinical research protocols at the Clinical Center and over 50,000 inpatient days and nearly 100,000 outpatient visits per year. Our Urologic Oncology Fellows also rotate on the Urology Service at other sites. Research in molecular genetic basis of urologic malignancies and work on development of new forms of diagnosis/therapy for patients with these cancers is done in collaboration with other branches/labs at the NCI and is continually evolving. Solid grounding in cancer genetics and molecular biology and unique interface between basic and clinical research; also includes participation in lab/seminars/ journal clubs, NIH-wide lectures, seminars, and on-campus, short-term molecular biology and clinical research training courses, weekly clinical urology conferences and clinical trials of new forms of therapy for patients with localized as well as advanced forms of urologic cancers.
Apply to this program through the NIH Graduate Medical Education Application System.